In this study, we found that LGSP remarkably decreased the growth of a HeLa xenograft tumor, and the inhibition rate of LGSP was higher than that for GSP, indicating that LGSP had better anti-cervical cancer activity in vivo, which was consistent with our in vitro studies. This evidence concerns the gene GNAS and neoplasm.